Comparison of chemotherapy plus bevacizumab vs. chemotherapy alone as third-line treatment or beyond for advanced non-small cell lung cancer: A propensity score-matched analysis.
Hu B, Zhou X, Liu Y, Li Q, Xiang M, Zou B, Peng F, Huang M, Gong Y, Zhu J, Wang Y, Ren L, Xu Y, Zhang Y, Li Y, Yu M, Xue J, Deng L, Wang J, Ding Z, Lu Y.
Hu B, et al. Among authors: wang j, wang y.
Oncol Lett. 2018 Apr;15(4):5671-5679. doi: 10.3892/ol.2018.8064. Epub 2018 Feb 15.
Oncol Lett. 2018.
PMID: 29556304
Free PMC article.